FI20020807A0 - Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita - Google Patents
Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineitaInfo
- Publication number
- FI20020807A0 FI20020807A0 FI20020807A FI20020807A FI20020807A0 FI 20020807 A0 FI20020807 A0 FI 20020807A0 FI 20020807 A FI20020807 A FI 20020807A FI 20020807 A FI20020807 A FI 20020807A FI 20020807 A0 FI20020807 A0 FI 20020807A0
- Authority
- FI
- Finland
- Prior art keywords
- vap
- monoclonal antibodies
- humanized anti
- novel humanized
- novel
- Prior art date
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020807A FI20020807A0 (fi) | 2002-04-29 | 2002-04-29 | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita |
| PCT/FI2003/000330 WO2003093319A1 (en) | 2002-04-29 | 2003-04-28 | Novel humanized anti-vap-1 monoclonal antibody |
| AU2003229799A AU2003229799A1 (en) | 2002-04-29 | 2003-04-28 | Novel humanized anti-vap-1 monoclonal antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20020807A FI20020807A0 (fi) | 2002-04-29 | 2002-04-29 | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20020807A0 true FI20020807A0 (fi) | 2002-04-29 |
Family
ID=8563846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20020807A FI20020807A0 (fi) | 2002-04-29 | 2002-04-29 | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003229799A1 (fi) |
| FI (1) | FI20020807A0 (fi) |
| WO (1) | WO2003093319A1 (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20050574A0 (fi) * | 2005-05-31 | 2005-05-31 | Faron Pharmaceuticals Oy | Koostumuksia, jotka kohdistuvat amiinioksidaaseihin in vivo |
| FI20075278A0 (fi) | 2007-04-20 | 2007-04-20 | Biotie Therapies Corp | Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet |
| UA112154C2 (uk) * | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
| CA2915163A1 (en) | 2013-06-12 | 2014-12-18 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
| CA3007768A1 (en) | 2015-12-07 | 2017-06-15 | Benevolentai Cambridge Limited | Vap-1 inhibitors for treating pain |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU217175B (hu) * | 1992-06-09 | 1999-12-28 | Oy Biotie Therapies Ltd. | Új belhámvaszkuláris protein-1 (VAP-1), amely emberben a limfociták kötődését mediálja |
| WO1998053049A1 (en) * | 1997-05-23 | 1998-11-26 | Biotie Therapies Ltd. | Vascular adhesion protein-1 having amine oxidase activity |
| GB9809951D0 (en) * | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
-
2002
- 2002-04-29 FI FI20020807A patent/FI20020807A0/fi unknown
-
2003
- 2003-04-28 AU AU2003229799A patent/AU2003229799A1/en not_active Abandoned
- 2003-04-28 WO PCT/FI2003/000330 patent/WO2003093319A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003229799A1 (en) | 2003-11-17 |
| WO2003093319A1 (en) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2012019I2 (el) | Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20 | |
| DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
| DK1501856T3 (da) | Anti-HER2 antistofvarianter | |
| EE200300179A (et) | Humaniseeritud LT-ß-R-i vastased antikehad | |
| AU2003264009A8 (en) | Humanized rabbit antibodies | |
| NO20054351D0 (no) | Monoklonalt antistoff og hybridom som produserer dette | |
| ATE480564T1 (de) | Monoklonaler anti-mensch-tenascin-antikörper | |
| NO20044347L (no) | Anti-alfavbeta6-antistoff | |
| IL191217A (en) | Anti-17 mantle monoclonal antibody | |
| DK1599504T3 (da) | Modificeret antistof | |
| IS6982A (is) | Mótefni gegn VLA-1 | |
| PL2177537T3 (pl) | Przeciwciała przeciw MadCAM | |
| EP1499352A4 (en) | ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES | |
| EP1761566A4 (en) | HUMANIZED MONOCLONAL ANTI-DAY-72 ANTIBODIES | |
| EP1567555A4 (en) | HUMANIZED ANTIBODIES AGAINST CHEMOTOXIC MONOCYTE PROTEINS | |
| EE200300569A (et) | CD44v6-spetsiifilised antikehad | |
| BRPI0509495A2 (pt) | anticorpo humanizado | |
| FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
| NO20044145L (no) | Assay for anti-INGAP antistoffer | |
| FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
| DE112004002660D2 (de) | Humaner monoklonaler Antikörper mit fettsenkender Wirkung | |
| EP1483292A4 (en) | MONOCLONAL ANTIBODIES WITH CROSS-REACTION AGAINST BACTERIAL COLLAGEN BINDING PROTEINS | |
| EP1712564A4 (en) | MONOCLONAL ANTIBODY ANTI-NC1 | |
| ATE535259T1 (de) | Immunogener, monoklonaler antikörper | |
| DE60239895D1 (de) | Humanisierte super-antikörper |